Heart attack recovery: could Lower-Dose statins be just as good?
NCT ID NCT06782243
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at whether moderate-dose statins work as well as high-dose statins in lowering 'bad' LDL cholesterol after a heart attack. 190 adults aged 25-85 took either a moderate or high dose of atorvastatin or rosuvastatin daily for 3 months. The goal was to see if both groups could achieve a 50% or greater drop in LDL cholesterol, while also tracking side effects like muscle pain and liver issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
statins (atorvastatin and rosuvastatin)
What this could lead to
If moderate-intensity statins work as well as high-intensity ones, doctors may prescribe lower doses to reduce side effects and costs for heart attack patients.
What could go wrong
This is a small, completed trial with only 190 participants. The results may not apply to all patients, and moderate doses might not lower cholesterol enough for some high-risk individuals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MTI-KTH (Medical Teaching Institution-Khyber Teaching Hospital), Peshawar-Pakistan
Peshawar, Khyber Pakhtunkhwa, 25000, Pakistan